Literature DB >> 20923588

Classification of evidence in decision-analytic models of cost-effectiveness: a content analysis of published reports.

Suzy Paisley1.   

Abstract

OBJECTIVES: The aim of this study was to assess systematically the scope of evidence and purposes for which evidence is used in decision-analytic models of cost-effectiveness and to assess the implications for search methods.
METHODS: A content analysis of published reports of models was undertaken. Details of cited sources were extracted and categorized according to three dimensions; type of information provided by the evidence, type of source from which the evidence was drawn and type of modeling activity supported by the evidence. The analysis was used to generate a classification of evidence. Relationships within and between the categories within the classification were sought and the implications for searching considered.
RESULTS: The classification generated fourteen types of information, seven types of sources of evidence and five modeling activities supported by evidence. A broad range of evidence was identified drawn from a diverse range of sources including both research-based and non-research-based sources. The use of evidence was not restricted to the population of model parameters but was used to inform the development of the modeling framework and to justify the analytical and methodological approach.
CONCLUSIONS: Decision-analytic models use evidence to support all aspects of model development. The classification of evidence defines in depth the role of evidence in modeling. It can be used to inform the systematic identification of evidence.

Mesh:

Year:  2010        PMID: 20923588     DOI: 10.1017/S026646231000098X

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  4 in total

1.  Identification of Evidence for Key Parameters in Decision-Analytic Models of Cost Effectiveness: A Description of Sources and a Recommended Minimum Search Requirement.

Authors:  Suzy Paisley
Journal:  Pharmacoeconomics       Date:  2016-06       Impact factor: 4.981

Review 2.  Structural Design and Data Requirements for Simulation Modelling in HIV/AIDS: A Narrative Review.

Authors:  Xiao Zang; Emanuel Krebs; Linwei Wang; Brandon D L Marshall; Reuben Granich; Bruce R Schackman; Julio S G Montaner; Bohdan Nosyk
Journal:  Pharmacoeconomics       Date:  2019-10       Impact factor: 4.981

3.  Methods to construct a step-by-step beginner's guide to decision analytic cost-effectiveness modeling.

Authors:  Tamlyn Rautenberg; Claire Hulme; Richard Edlin
Journal:  Clinicoecon Outcomes Res       Date:  2016-10-11

4.  Developing a dynamic HIV transmission model for 6 U.S. cities: An evidence synthesis.

Authors:  Emanuel Krebs; Benjamin Enns; Linwei Wang; Xiao Zang; Dimitra Panagiotoglou; Carlos Del Rio; Julia Dombrowski; Daniel J Feaster; Matthew Golden; Reuben Granich; Brandon Marshall; Shruti H Mehta; Lisa Metsch; Bruce R Schackman; Steffanie A Strathdee; Bohdan Nosyk
Journal:  PLoS One       Date:  2019-05-30       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.